Urenco Isotopes provides the world with stable and medical isotopes for medical, research and industry uses.
Visit our Isotopes websiteSee what actions we are taking to achieve net zero by 2040 in our net zero transition plan.
Read it hereOur increased order book and solid financial and operational performance provide basis for future growth.
Read our latest report10 June 2016
U-Battery was delighted to co-sponsor the ‘Small Modular Reactors: What, Why and When? conference at St. Ermin’s Hotel, London on 8-9 June 2016.
Delegates from across the nuclear industry attended the conference. U-Battery provided an insight into the design of the reactor and how it could provide high-efficiency, low-carbon electricity in an inherently safe way.
Steve Threlfall, General Manager, U-Battery comments:
“The SMR conference was a great opportunity to engage with an interested audience. We are now entering the next phase of U-Battery development which will deliver the Basic Design and commence Safety Case Preparation.”
The conference explored what constitutes a Small Modular Reactors (SMR), why they might be required in the UK, and when they might be deployed.
U-Battery is a micro-modular reactor being developed by Urenco, AMEC FW, Atkins, Cammell-Laird and Laing O’Rourke.
About Urenco
Urenco is an international supplier of enrichment services and fuel cycle products with sustainability at the core of its business. Operating in a pivotal area of the nuclear fuel supply chain for 50 years, Urenco facilitates zero carbon electricity generation for consumers around the world.
With its head office near London, UK, Urenco’s global presence ensures diversity and security of supply for customers through enrichment facilities in Germany, the Netherlands, the UK and the USA. Using centrifuge technology designed and developed by Urenco, and through the expertise of our people, the Urenco Group provides safe, cost effective and reliable services; operating within a framework of high environmental, social and governance standards, complementing international safeguards.
Urenco is committed to continued investment in the responsible management of nuclear materials; innovation activities with clear sustainability benefits, such as nuclear medicine, industrial efficiency and research; and nurturing the next generation of scientists and engineers.
Media enquiries